Bridgeway Capital Management’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$193K	Sell	62,900 -73,400	-54%	-$225K	﹤0.01%	969
2025 Q1	$263K	Buy	136,300 +56,300	+70%	+$109K	0.01%	864
2024 Q4	$299K	Buy	+80,000	New	+$299K	0.01%	923